 | • レポートコード：MRC2Q12-03472 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、β-ニコチンアミドモノヌクレオチドのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 β-ニコチンアミドモノヌクレオチドのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 β-ニコチンアミドモノヌクレオチドの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 β-ニコチンアミドモノヌクレオチドのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのβ-ニコチンアミドモノヌクレオチドの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のβ-ニコチンアミドモノヌクレオチドの売上および2028年までの予測に焦点を当てています。 β-ニコチンアミドモノヌクレオチドのグローバル主要企業には、GeneHarbor、Quicksilver Scientific、Age Science、Herbalmax、Genex Formulas、Nutravita、Shinkowa Pharmaceutical、Oriental Yeast、Maac10 Formulas、EffePharm、Nutriop、Bontac、CELFULL、ChromaDex、Kingdomwayなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 β-ニコチンアミドモノヌクレオチド市場は、タイプとアプリケーションによって区分されます。世界のβ-ニコチンアミドモノヌクレオチド市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 98%以上、＜98% 【アプリケーション別セグメント】 医薬品、健康食品、化粧品、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - β-ニコチンアミドモノヌクレオチド製品概要 - タイプ別市場（98%以上、＜98%） - アプリケーション別市場（医薬品、健康食品、化粧品、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のβ-ニコチンアミドモノヌクレオチド販売量予測2017-2028 - 世界のβ-ニコチンアミドモノヌクレオチド売上予測2017-2028 - β-ニコチンアミドモノヌクレオチドの地域別販売量 - β-ニコチンアミドモノヌクレオチドの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別β-ニコチンアミドモノヌクレオチド販売量 - 主要メーカー別β-ニコチンアミドモノヌクレオチド売上 - 主要メーカー別β-ニコチンアミドモノヌクレオチド価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（98%以上、＜98%） - β-ニコチンアミドモノヌクレオチドのタイプ別販売量 - β-ニコチンアミドモノヌクレオチドのタイプ別売上 - β-ニコチンアミドモノヌクレオチドのタイプ別価格 ・アプリケーション別市場規模（医薬品、健康食品、化粧品、その他） - β-ニコチンアミドモノヌクレオチドのアプリケーション別販売量 - β-ニコチンアミドモノヌクレオチドのアプリケーション別売上 - β-ニコチンアミドモノヌクレオチドのアプリケーション別価格 ・北米市場 - 北米のβ-ニコチンアミドモノヌクレオチド市場規模（タイプ別、アプリケーション別） - 主要国別のβ-ニコチンアミドモノヌクレオチド市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのβ-ニコチンアミドモノヌクレオチド市場規模（タイプ別、アプリケーション別） - 主要国別のβ-ニコチンアミドモノヌクレオチド市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のβ-ニコチンアミドモノヌクレオチド市場規模（タイプ別、アプリケーション別） - 主要国別のβ-ニコチンアミドモノヌクレオチド市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のβ-ニコチンアミドモノヌクレオチド市場規模（タイプ別、アプリケーション別） - 主要国別のβ-ニコチンアミドモノヌクレオチド市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのβ-ニコチンアミドモノヌクレオチド市場規模（タイプ別、アプリケーション別） - 主要国別のβ-ニコチンアミドモノヌクレオチド市場規模（トルコ、サウジアラビア） ・企業情報 GeneHarbor、Quicksilver Scientific、Age Science、Herbalmax、Genex Formulas、Nutravita、Shinkowa Pharmaceutical、Oriental Yeast、Maac10 Formulas、EffePharm、Nutriop、Bontac、CELFULL、ChromaDex、Kingdomway ・産業チェーン及び販売チャネル分析 - β-ニコチンアミドモノヌクレオチドの産業チェーン分析 - β-ニコチンアミドモノヌクレオチドの原材料 - β-ニコチンアミドモノヌクレオチドの生産プロセス - β-ニコチンアミドモノヌクレオチドの販売及びマーケティング - β-ニコチンアミドモノヌクレオチドの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - β-ニコチンアミドモノヌクレオチドの産業動向 - β-ニコチンアミドモノヌクレオチドのマーケットドライバー - β-ニコチンアミドモノヌクレオチドの課題 - β-ニコチンアミドモノヌクレオチドの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for β-Nicotinamide Mononucleotide estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for β-Nicotinamide Mononucleotide is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for β-Nicotinamide Mononucleotide is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for β-Nicotinamide Mononucleotide is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of β-Nicotinamide Mononucleotide include GeneHarbor, Quicksilver Scientific, Age Science, Herbalmax, Genex Formulas, Nutravita, Shinkowa Pharmaceutical, Oriental Yeast and Maac10 Formulas, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the β-Nicotinamide Mononucleotide production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of β-Nicotinamide Mononucleotide by region (region level and country level), by company, by Purity and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the β-Nicotinamide Mononucleotide manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional β-Nicotinamide Mononucleotide market. Further, it explains the major drivers and regional dynamics of the global β-Nicotinamide Mononucleotide market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
GeneHarbor
Quicksilver Scientific
Age Science
Herbalmax
Genex Formulas
Nutravita
Shinkowa Pharmaceutical
Oriental Yeast
Maac10 Formulas
EffePharm
Nutriop
Bontac
CELFULL
ChromaDex
Kingdomway
Market Segments
This report has explored the key segments: by Purity and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
β-Nicotinamide Mononucleotide Segment by Purity
Above 98%
＜98%
β-Nicotinamide Mononucleotide Segment by Application
Drug
Health Products
Cosmetic
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the β-Nicotinamide Mononucleotide production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the β-Nicotinamide Mononucleotide market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for β-Nicotinamide Mononucleotide, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of β-Nicotinamide Mononucleotide, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for β-Nicotinamide Mononucleotide, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the β-Nicotinamide Mononucleotide sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global β-Nicotinamide Mononucleotide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for β-Nicotinamide Mononucleotide sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GeneHarbor, Quicksilver Scientific, Age Science, Herbalmax, Genex Formulas, Nutravita, Shinkowa Pharmaceutical, Oriental Yeast and Maac10 Formulas, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: β-Nicotinamide Mononucleotide capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of β-Nicotinamide Mononucleotide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of β-Nicotinamide Mononucleotide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by purity, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by purity, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by purity, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by purity, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by purity, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, β-Nicotinamide Mononucleotide sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
1 Study Coverage
1.1 β-Nicotinamide Mononucleotide Product Introduction
1.2 Market by Purity
1.2.1 Global β-Nicotinamide Mononucleotide Market Size by Purity, 2017 VS 2021 VS 2028
1.2.2 Above 98%
1.2.3 ＜98%
1.3 Market by Application
1.3.1 Global β-Nicotinamide Mononucleotide Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Drug
1.3.3 Health Products
1.3.4 Cosmetic
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global β-Nicotinamide Mononucleotide Production
2.1 Global β-Nicotinamide Mononucleotide Production Capacity (2017-2028)
2.2 Global β-Nicotinamide Mononucleotide Production by Region: 2017 VS 2021 VS 2028
2.3 Global β-Nicotinamide Mononucleotide Production by Region
2.3.1 Global β-Nicotinamide Mononucleotide Historic Production by Region (2017-2022)
2.3.2 Global β-Nicotinamide Mononucleotide Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global β-Nicotinamide Mononucleotide Sales in Volume & Value Estimates and Forecasts
3.1 Global β-Nicotinamide Mononucleotide Sales Estimates and Forecasts 2017-2028
3.2 Global β-Nicotinamide Mononucleotide Revenue Estimates and Forecasts 2017-2028
3.3 Global β-Nicotinamide Mononucleotide Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global β-Nicotinamide Mononucleotide Sales by Region
3.4.1 Global β-Nicotinamide Mononucleotide Sales by Region (2017-2022)
3.4.2 Global Sales β-Nicotinamide Mononucleotide by Region (2023-2028)
3.5 Global β-Nicotinamide Mononucleotide Revenue by Region
3.5.1 Global β-Nicotinamide Mononucleotide Revenue by Region (2017-2022)
3.5.2 Global β-Nicotinamide Mononucleotide Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global β-Nicotinamide Mononucleotide Production Capacity by Manufacturers
4.2 Global β-Nicotinamide Mononucleotide Sales by Manufacturers
4.2.1 Global β-Nicotinamide Mononucleotide Sales by Manufacturers (2017-2022)
4.2.2 Global β-Nicotinamide Mononucleotide Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of β-Nicotinamide Mononucleotide in 2021
4.3 Global β-Nicotinamide Mononucleotide Revenue by Manufacturers
4.3.1 Global β-Nicotinamide Mononucleotide Revenue by Manufacturers (2017-2022)
4.3.2 Global β-Nicotinamide Mononucleotide Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by β-Nicotinamide Mononucleotide Revenue in 2021
4.4 Global β-Nicotinamide Mononucleotide Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global β-Nicotinamide Mononucleotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global β-Nicotinamide Mononucleotide Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Purity
5.1 Global β-Nicotinamide Mononucleotide Sales by Purity
5.1.1 Global β-Nicotinamide Mononucleotide Historical Sales by Purity (2017-2022)
5.1.2 Global β-Nicotinamide Mononucleotide Forecasted Sales by Purity (2023-2028)
5.1.3 Global β-Nicotinamide Mononucleotide Sales Market Share by Purity (2017-2028)
5.2 Global β-Nicotinamide Mononucleotide Revenue by Purity
5.2.1 Global β-Nicotinamide Mononucleotide Historical Revenue by Purity (2017-2022)
5.2.2 Global β-Nicotinamide Mononucleotide Forecasted Revenue by Purity (2023-2028)
5.2.3 Global β-Nicotinamide Mononucleotide Revenue Market Share by Purity (2017-2028)
5.3 Global β-Nicotinamide Mononucleotide Price by Purity
5.3.1 Global β-Nicotinamide Mononucleotide Price by Purity (2017-2022)
5.3.2 Global β-Nicotinamide Mononucleotide Price Forecast by Purity (2023-2028)
6 Market Size by Application
6.1 Global β-Nicotinamide Mononucleotide Sales by Application
6.1.1 Global β-Nicotinamide Mononucleotide Historical Sales by Application (2017-2022)
6.1.2 Global β-Nicotinamide Mononucleotide Forecasted Sales by Application (2023-2028)
6.1.3 Global β-Nicotinamide Mononucleotide Sales Market Share by Application (2017-2028)
6.2 Global β-Nicotinamide Mononucleotide Revenue by Application
6.2.1 Global β-Nicotinamide Mononucleotide Historical Revenue by Application (2017-2022)
6.2.2 Global β-Nicotinamide Mononucleotide Forecasted Revenue by Application (2023-2028)
6.2.3 Global β-Nicotinamide Mononucleotide Revenue Market Share by Application (2017-2028)
6.3 Global β-Nicotinamide Mononucleotide Price by Application
6.3.1 Global β-Nicotinamide Mononucleotide Price by Application (2017-2022)
6.3.2 Global β-Nicotinamide Mononucleotide Price Forecast by Application (2023-2028)
7 North America
7.1 North America β-Nicotinamide Mononucleotide Market Size by Purity
7.1.1 North America β-Nicotinamide Mononucleotide Sales by Purity (2017-2028)
7.1.2 North America β-Nicotinamide Mononucleotide Revenue by Purity (2017-2028)
7.2 North America β-Nicotinamide Mononucleotide Market Size by Application
7.2.1 North America β-Nicotinamide Mononucleotide Sales by Application (2017-2028)
7.2.2 North America β-Nicotinamide Mononucleotide Revenue by Application (2017-2028)
7.3 North America β-Nicotinamide Mononucleotide Sales by Country
7.3.1 North America β-Nicotinamide Mononucleotide Sales by Country (2017-2028)
7.3.2 North America β-Nicotinamide Mononucleotide Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe β-Nicotinamide Mononucleotide Market Size by Purity
8.1.1 Europe β-Nicotinamide Mononucleotide Sales by Purity (2017-2028)
8.1.2 Europe β-Nicotinamide Mononucleotide Revenue by Purity (2017-2028)
8.2 Europe β-Nicotinamide Mononucleotide Market Size by Application
8.2.1 Europe β-Nicotinamide Mononucleotide Sales by Application (2017-2028)
8.2.2 Europe β-Nicotinamide Mononucleotide Revenue by Application (2017-2028)
8.3 Europe β-Nicotinamide Mononucleotide Sales by Country
8.3.1 Europe β-Nicotinamide Mononucleotide Sales by Country (2017-2028)
8.3.2 Europe β-Nicotinamide Mononucleotide Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific β-Nicotinamide Mononucleotide Market Size by Purity
9.1.1 Asia Pacific β-Nicotinamide Mononucleotide Sales by Purity (2017-2028)
9.1.2 Asia Pacific β-Nicotinamide Mononucleotide Revenue by Purity (2017-2028)
9.2 Asia Pacific β-Nicotinamide Mononucleotide Market Size by Application
9.2.1 Asia Pacific β-Nicotinamide Mononucleotide Sales by Application (2017-2028)
9.2.2 Asia Pacific β-Nicotinamide Mononucleotide Revenue by Application (2017-2028)
9.3 Asia Pacific β-Nicotinamide Mononucleotide Sales by Region
9.3.1 Asia Pacific β-Nicotinamide Mononucleotide Sales by Region (2017-2028)
9.3.2 Asia Pacific β-Nicotinamide Mononucleotide Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America β-Nicotinamide Mononucleotide Market Size by Purity
10.1.1 Latin America β-Nicotinamide Mononucleotide Sales by Purity (2017-2028)
10.1.2 Latin America β-Nicotinamide Mononucleotide Revenue by Purity (2017-2028)
10.2 Latin America β-Nicotinamide Mononucleotide Market Size by Application
10.2.1 Latin America β-Nicotinamide Mononucleotide Sales by Application (2017-2028)
10.2.2 Latin America β-Nicotinamide Mononucleotide Revenue by Application (2017-2028)
10.3 Latin America β-Nicotinamide Mononucleotide Sales by Country
10.3.1 Latin America β-Nicotinamide Mononucleotide Sales by Country (2017-2028)
10.3.2 Latin America β-Nicotinamide Mononucleotide Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa β-Nicotinamide Mononucleotide Market Size by Purity
11.1.1 Middle East and Africa β-Nicotinamide Mononucleotide Sales by Purity (2017-2028)
11.1.2 Middle East and Africa β-Nicotinamide Mononucleotide Revenue by Purity (2017-2028)
11.2 Middle East and Africa β-Nicotinamide Mononucleotide Market Size by Application
11.2.1 Middle East and Africa β-Nicotinamide Mononucleotide Sales by Application (2017-2028)
11.2.2 Middle East and Africa β-Nicotinamide Mononucleotide Revenue by Application (2017-2028)
11.3 Middle East and Africa β-Nicotinamide Mononucleotide Sales by Country
11.3.1 Middle East and Africa β-Nicotinamide Mononucleotide Sales by Country (2017-2028)
11.3.2 Middle East and Africa β-Nicotinamide Mononucleotide Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 GeneHarbor
12.1.1 GeneHarbor Corporation Information
12.1.2 GeneHarbor Overview
12.1.3 GeneHarbor β-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 GeneHarbor β-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 GeneHarbor Recent Developments
12.2 Quicksilver Scientific
12.2.1 Quicksilver Scientific Corporation Information
12.2.2 Quicksilver Scientific Overview
12.2.3 Quicksilver Scientific β-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Quicksilver Scientific β-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Quicksilver Scientific Recent Developments
12.3 Age Science
12.3.1 Age Science Corporation Information
12.3.2 Age Science Overview
12.3.3 Age Science β-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Age Science β-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Age Science Recent Developments
12.4 Herbalmax
12.4.1 Herbalmax Corporation Information
12.4.2 Herbalmax Overview
12.4.3 Herbalmax β-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Herbalmax β-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Herbalmax Recent Developments
12.5 Genex Formulas
12.5.1 Genex Formulas Corporation Information
12.5.2 Genex Formulas Overview
12.5.3 Genex Formulas β-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Genex Formulas β-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Genex Formulas Recent Developments
12.6 Nutravita
12.6.1 Nutravita Corporation Information
12.6.2 Nutravita Overview
12.6.3 Nutravita β-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Nutravita β-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Nutravita Recent Developments
12.7 Shinkowa Pharmaceutical
12.7.1 Shinkowa Pharmaceutical Corporation Information
12.7.2 Shinkowa Pharmaceutical Overview
12.7.3 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Shinkowa Pharmaceutical Recent Developments
12.8 Oriental Yeast
12.8.1 Oriental Yeast Corporation Information
12.8.2 Oriental Yeast Overview
12.8.3 Oriental Yeast β-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Oriental Yeast β-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Oriental Yeast Recent Developments
12.9 Maac10 Formulas
12.9.1 Maac10 Formulas Corporation Information
12.9.2 Maac10 Formulas Overview
12.9.3 Maac10 Formulas β-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Maac10 Formulas β-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Maac10 Formulas Recent Developments
12.10 EffePharm
12.10.1 EffePharm Corporation Information
12.10.2 EffePharm Overview
12.10.3 EffePharm β-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 EffePharm β-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 EffePharm Recent Developments
12.11 Nutriop
12.11.1 Nutriop Corporation Information
12.11.2 Nutriop Overview
12.11.3 Nutriop β-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Nutriop β-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Nutriop Recent Developments
12.12 Bontac
12.12.1 Bontac Corporation Information
12.12.2 Bontac Overview
12.12.3 Bontac β-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Bontac β-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Bontac Recent Developments
12.13 CELFULL
12.13.1 CELFULL Corporation Information
12.13.2 CELFULL Overview
12.13.3 CELFULL β-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 CELFULL β-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 CELFULL Recent Developments
12.14 ChromaDex
12.14.1 ChromaDex Corporation Information
12.14.2 ChromaDex Overview
12.14.3 ChromaDex β-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 ChromaDex β-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 ChromaDex Recent Developments
12.15 Kingdomway
12.15.1 Kingdomway Corporation Information
12.15.2 Kingdomway Overview
12.15.3 Kingdomway β-Nicotinamide Mononucleotide Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 Kingdomway β-Nicotinamide Mononucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Kingdomway Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 β-Nicotinamide Mononucleotide Industry Chain Analysis
13.2 β-Nicotinamide Mononucleotide Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 β-Nicotinamide Mononucleotide Production Mode & Process
13.4 β-Nicotinamide Mononucleotide Sales and Marketing
13.4.1 β-Nicotinamide Mononucleotide Sales Channels
13.4.2 β-Nicotinamide Mononucleotide Distributors
13.5 β-Nicotinamide Mononucleotide Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 β-Nicotinamide Mononucleotide Industry Trends
14.2 β-Nicotinamide Mononucleotide Market Drivers
14.3 β-Nicotinamide Mononucleotide Market Challenges
14.4 β-Nicotinamide Mononucleotide Market Restraints
15 Key Finding in The Global β-Nicotinamide Mononucleotide Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer